Michel Clavel

发表

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials.

S. Culine, P. Hérait, J. Armand, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation

M. Aapro, M. Marty, A. Iliadis, 2004, Cancer Chemotherapy and Pharmacology.